Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Global Alliance of Leading Drug Discovery and Development Centres

UK flag

MRC funds UK research using 22 AstraZeneca compounds

Provides £7m for projects covering Alzheimer’s, cancer, lung disease and rare conditions

- PMLiVE

Menarini signs €800m cancer antibody deal

Will work with Oxford BioTherapeutics on antibody-drug conjugates

- PMLiVE

AstraZeneca signs IBS collaboration with Ironwood in China

Deal will also see Ironwood’s US sales force promote Nexium for gastroesophageal reflux disease

- PMLiVE

Diabetes care recognised at UK awards

Joint working between pharma, NHS and patient organisations key among winners at QiC Diabetes 2012

Pharma deals during September 2012

In this regular review of deals we focus on transactions announced during September 2012

Ten pharma firms team up on new drug development

Joint venture to take on some of the key challenges and bottlenecks in drug development

- PMLiVE

Sanofi taps Oncodesign for kinase inhibitor platform

French firms form €130m alliance

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

- PMLiVE

AstraZeneca forges CRO alliance to bring biologic to China

MedImmune Subsidiary forms joint venture with WuXi

WorldOne signs real-time patient perception partnership

Health data company will collaborate with patient intelligence platform Treato

- PMLiVE

GSK’s Olympic doping facility to research personalised medicines after Games

MRC-NIHR Phenome Centre is “phenomenal legacy” from London 2012 says MRC’s Prof John Savill

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links